Cost-related delayed or forgone care was associated with 78% higher odds of an ED visit among Latino adults, indicating ...

Rebecca L. Siegel, MPH, lead author of the “Colorectal Cancer Statistics, 2026” report recently published in CA: A Cancer ...

Lindsey Dawson, MA, speaks about how budget decisions regarding ADAPs in Florida could affect patients with HIV should these decisions be made permanent.

A systematic review detailed how chronic kidney disease (CKD) imposes substantial financial, productivity, and quality-of-life burdens on both patients and their informal caregivers in the United ...

CMS Innovation Center models are expanding prevention levers via outcomes measurement, functional status and well-being metrics, and beneficiary incentives, including ACO REACH mechanisms to reward ...

ADAPs in Florida could affect patients with HIV should these decisions be made permanent. 259 Prospect Plains Rd, Bldg H Cranbury, NJ 08512 ...

MajesTEC-9 supports moving teclistamab earlier in myeloma treatment, with robust PFS and OS gains over standard care in the second-line setting, notes Roberto Mina, MD. AJMC: Given the 71% reduction ...

A continuous postoperative sivelestat infusion reduced ARDS rates versus placebo after cardiovascular surgery (16.8% vs 31.2%; P < .001). Ninety-day all-cause mortality was lower with sivelestat ...

CMS is pursuing empiric fee-schedule accuracy in original Medicare (eg, validating procedure time assumptions) while rapidly expanding MSSP and CMMI pathways to move beyond unmanaged fee-for-service.

Michael Bernstein, MD, discusses how AI-assisted radiology workflows affect liability, automation bias, and patient safety in diagnostic imaging. As artificial intelligence (AI) becomes more embedded ...

Risk stratification used a validated 5-year absolute risk calculator incorporating breast density, family history, biopsy history, race/ethnicity, and menopausal status, with reassessment every five ...

Resmetirom improved HRQOL versus placebo in early MASH, particularly abdominal symptoms, disease-related worry, and health distress, with onset by week 24 and durability through week 52. Baseline ...